TGA Approval

SUNLENCA lenacapavir (as sodium) 463.5 mg/1.5 mL solution for injection vial (386895)

ARTG ID

386895

ARTG Name

SUNLENCA lenacapavir (as sodium) 463.5 mg/1.5 mL solution for injection vial

Sponsor

Gilead Sciences Pty Ltd

ARTG Date

March 27, 2023

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

GILEAD SCIENCES PTY LIMITED

https://medical-cdn.nocode.com/drug_tga/8427e27b3e6d432d7d6ad0900966e6c9.pdf

https://medical-cdn.nocode.com/drug_tga/9ea0c8d55e86c33b59441be9c42ca8da.pdf

Ingredient Name

lenacapavir sodium

Empowering clinical research with data-driven insights and AI-powered tools.

SUNLENCA lenacapavir (as sodium) 463.5 mg/1.5 mL solution for injection vial (386895) - TGA 批准文号 | MedPath